Incyte Other Non-Current Liabilities decreased by 23.4% to $126.59M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 27.9%, from $175.59M to $126.59M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 23.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $57.59M | $62.31M | $70.41M | $69.47M | $76.06M | $74.68M | $99.24M | $118.41M | $139.81M | $133.07M | $149.15M | $151.11M | $142.10M | $144.68M | $167.54M | $175.59M | $179.91M | $171.18M | $165.27M | $126.59M |
| QoQ Change | — | +8.2% | +13.0% | -1.3% | +9.5% | -1.8% | +32.9% | +19.3% | +18.1% | -4.8% | +12.1% | +1.3% | -6.0% | +1.8% | +15.8% | +4.8% | +2.5% | -4.9% | -3.5% | -23.4% |
| YoY Change | — | — | — | — | +32.1% | +19.9% | +40.9% | +70.4% | +83.8% | +78.2% | +50.3% | +27.6% | +1.6% | +8.7% | +12.3% | +16.2% | +26.6% | +18.3% | -1.4% | -27.9% |